Notícias

Whenever RocketLab reports earnings these days, investors and analysts are far more interested in Neutron rocket updates.

Costco's valuation looks expensive, but its business keeps delivering.

The Home Depot, Inc. will release its second quarter earnings report before the opening bell on Tuesday, Aug. 18. Analysts expect the company to report quarterly earnings of $4.73 per share, up from $4.68 per share in the year-ago period....

HIVE Digital Technologies reported sharply higher revenue for its fiscal first quarter of 2027, though a large one-time charge tied to a tax dispute in Sweden pushed the company to a net loss. HIVE (Nasdaq: HIVE), founded in 2017, mines Bitcoin using renewable energy and runs a growing ...

The Dow Jones Industrial Average finished the week down 0.6% on Friday, snapping a two-week winning streak.

What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 44.2%, hitting $63.36. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

A multiple this low usually means the market smells decline -- yet the latest quarter set records.

Over the past six months, Zoom has been a great trade, beating the S&P 500 by 10.4%. Its stock price has climbed to $109.49, representing a healthy 23.5% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

J. M. Smucker trades at $121.13 per share and has stayed right on track with the overall market, gaining 14% over the last six months. At the same time, the S&P 500 has returned 13.1%.

The neocloud company is scaling its gigawatt portfolio quickly.

Alphabet recently raised its artificial intelligence (AI) infrastructure budget for the year.

Home Depot faces an unexpected leadership change just days before earnings, but Tuesday's report should matter considerably more for HD stock.

Wall Street sees booming cloud growth as a sign that AI spending is giving a return on investment.

Morgan Stanley sees U. S. corporate earnings momentum spreading well beyond the largest technology companies, creating opportunities in quality stocks, artificial intelligence adopters, large-cap financials and consumer discretionary goods.

The midstream company raised its guidance for yearly adjusted EBITDA during its second-quarter earnings report.

JPMorgan has increased its 2026 S&P 500 price target to 8,000 from 7,800, pointing to an exceptionally strong second-quarter earnings season and growing evidence that massive artificial intelligence investments are translating into stronger business performance. The bank also raised its earnings forecasts for both 2026 and 2027, although elevated interest rates, geopolitical risks and heavy capital-market supply are keeping its valuation assumptions in check.

CoreWeave and Nebius are both benefiting from the AI infrastructure boom. Yet, one combines faster growth and stronger profitability with a much lighter debt burden.

Jain exercised options and sold shares to cover tax withholding from a vesting event, retaining close to 148,000 shares and 270,000 options outstanding.

This filing reports the exercise of vested options and tax withholding obligations.

Lifeway Foods Inc (LWAY) posts 27th consecutive quarter of growth with $66.9M in net sales, but margin compression from milk and resin costs weighs on profitability.

MACOM currently trades at $308.10 and has been a dream stock for shareholders. It’s returned 404% since August 2021, blowing past the S&P 500’s 72.8% gain. The company has also beaten the index over the past six months as its stock price is up 26.2% thanks to its solid quarterly results.

Acuity Brands trades at $360.33 and has moved in lockstep with the market. Its shares have returned 17.9% over the last six months while the S&P 500 has gained 13%.

What a fantastic six months it’s been for Figs. Shares of the company have skyrocketed 42.2%, hitting $14.58. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Oscar Health (OSCR) is back in focus after reporting second quarter 2026 results that swung from a loss to net income of $361.81 million and raising full year earnings guidance. See our latest analysis for Oscar Health. Oscar Health shares have been volatile around the earnings release, with an 11.9% drop reported after the outlook update. The stock still shows a 118.84% year to date share price return and a 109.46% 1 year total shareholder return, suggesting momentum remains strong despite...

Why Iovance Biotherapeutics stock is back in focus after Q2 earnings Iovance Biotherapeutics (IOVA) is back on investor radars after its second quarter 2026 earnings. The company reported higher revenue and a reduced net loss, and it reaffirmed full year revenue guidance. The quarter was driven by Amtagvi and Proleukin sales, and by progress across Iovance Biotherapeutics pipeline programs, including new regulatory approvals and Fast Track designations for lifileucel in certain soft tissue...

The rapid growth days of each company are probably over, but each stock remains an excellent choice for income investors.

AI-driven efficiencies are an underappreciated catalyst for the fintech company.

Moby summary of Sidus Space, Inc.'s Q2 2026 earnings call

QXO earnings and recent performance QXO (QXO) reported second quarter 2026 results on August 13, with sales of US$3.25b and a net loss of US$55m. Six month sales reached US$4.98b, with a net loss of US$282m. See our latest analysis for QXO. QXO's share price has come under pressure despite the recent earnings report and the completion of the TopBuild acquisition, with the stock down 10% over the past week and recording a 26% year to date share price decline and a 5 year total shareholder...

Unity’s second quarter results were marked by robust revenue growth and significant margin improvement, triggering a notable positive market response. Management cited the rapid adoption of its Vector AI-powered ad platform and a suite of product enhancements as primary drivers of performance. CEO Matthew Bromberg emphasized the impact of integrating runtime data and noted, “Our astounding performance is fueling a 63% year-over-year increase in our Strategic Grow business.” The company’s renewed